Alkermes (ALKS) Operating Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Alkermes (ALKS) Operating Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.03 Bn | 625.27 Bn | 17.26 Bn | 22.00 |
| 2 | AbbVie | 441.99 Bn | 435.42 Bn | 12.70 Bn | 613.00 |
| 3 | Merck | 366.30 Bn | 359.16 Bn | 12.21 Bn | -3,510.00 |
| 4 | Novartis Ag | 266.55 Bn | 258.86 Bn | 11.24 Bn | -164.00 |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | -611.00 |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn | -572.00 |
| 7 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | - |
| 8 | Incyte | 25.53 Bn | 20.99 Bn | 1.57 Bn | -194.00 |
| 9 | United Therapeutics | 21.51 Bn | 18.85 Bn | 683.80 Mn | -341.00 |
| 10 | Alkermes | 7.56 Bn | 6.91 Bn | 397.90 Mn | -2,010.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,010.00 |
| Mar 31, 2026 | -1,679.00 |
| Dec 31, 2025 | -2,273.00 |
| Sep 30, 2025 | -510.00 |
| Jun 30, 2025 | -373.00 |
| Mar 31, 2025 | -786.00 |
| Dec 31, 2024 | 2,336.00 |
| Sep 30, 2024 | 429.00 |
| Jun 30, 2024 | -1,803.00 |
| Mar 31, 2024 | 1,618.00 |
| Dec 31, 2023 | -2,347.00 |
| Sep 30, 2023 | 4,744.00 |
| Jun 30, 2023 | 5,803.00 |
| Mar 31, 2023 | 573.00 |
| Dec 31, 2022 | -195.00 |
| Sep 30, 2022 | -1,735.00 |
| Jun 30, 2022 | -1,393.00 |
| Mar 31, 2022 | -301.00 |
| Dec 31, 2021 | 5,086.00 |
| Sep 30, 2021 | -266.00 |